bibliographic entry 208 [be/208]
https://w3id.org/oc/corpus/be/208

is a
content
  • Konecny, GE, Finkler, N, Garcia, AA. Phase 2 study of second-line dovitinib (TKI258) in patients with fibroblast growth factor receptor 2 (FGFR2)-mutated or -nonmutated advanced and/or metastatic endometrial cancer. Ann Oncol. 2014; 25 ( suppl 4): LBA27.
references